Neumora Therapeutics Inc.
Organization details
- Legal name
- Neumora Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Watertown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NMRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001885522
- EIN
- 84-4367680
Board of directors
-
Alaa Halawa · DirectorSince 2023
-
David Piacquad · DirectorSince 2023
-
Henry O. Gosebruch · Director · President & CEOSince 2023
-
Joshua Pinto · Director · President & CEOSince 2026
- Since 2023
-
Matthew K. Fust · DirectorSince 2023
-
Maykin Ho · DirectorSince 2023
-
Paul L. Berns · Director · See RemarksSince 2023
Chief executives
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.4%
-
95.4%
-
95.6%
Board connections
5 of this board's directors also sit on 12 other boards. 12 are in the same sector.
-
Kardigan Inc. Same sectorvia Kristina Burow and Paul L. Berns
-
ANI Pharmaceuticals Inc. Same sectorvia Henry O. Gosebruch
-
Agios Pharmaceuticals Inc. Same sectorvia Maykin Ho
-
Atara Biotherapeutics Inc. Same sectorvia Matthew K. Fust
-
Beam Therapeutics Inc. Same sectorvia Kristina Burow
-
BioMarin Pharmaceutical Inc. Same sectorvia Maykin Ho
-
Boundless Bio Inc. Same sectorvia Kristina Burow
-
Electra Therapeutics Inc. Same sectorvia Matthew K. Fust
-
Gossamer Bio Inc. Same sectorvia Kristina Burow
-
Kyntra Bio Inc. Same sectorvia Maykin Ho
-
Scholar Rock Holding Corporation Same sectorvia Kristina Burow
-
Ultragenyx Pharmaceutical Inc. Same sectorvia Matthew K. Fust
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $784,117
- 15 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +20,553 | $0.72 | $14,798 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −20,553 | $1.59 | $32,679 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +21,055 | $0.72 | $15,160 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −21,055 | $1.60 | $33,688 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +67,741 | $0.72 | $48,774 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −67,741 | $1.51 | $102,289 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +21,685 | $0.72 | $15,613 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +45,026 | $0.72 | $32,419 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −66,711 | $1.51 | $100,734 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +13,268 | $0.72 | $9,553 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +17,732 | $0.72 | $12,767 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −31,000 | $1.65 | $51,150 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +30,918 | $0.72 | $22,261 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −30,918 | $1.65 | $51,015 |
| Aug 18, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +34,162 | $0.72 | $24,597 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Neumora Therapeutics Inc.
Who is the CEO of Neumora Therapeutics Inc.?
Henry O. Gosebruch has been Neumora Therapeutics Inc.'s President & CEO since September 2023.
How many directors are on Neumora Therapeutics Inc.'s board?
Neumora Therapeutics Inc.'s board has 8 directors: Alaa Halawa, David Piacquad, Henry O. Gosebruch, Joshua Pinto, Kristina Burow, Matthew K. Fust, Maykin Ho and Paul L. Berns.
Are Neumora Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Neumora Therapeutics Inc. insiders made no open-market purchases and sold $784,117 of shares in 15 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neumora-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.